Literature DB >> 35672462

Toward pre-treatment prediction of biologic DMARD response in RA.

Robert Phillips1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35672462     DOI: 10.1038/s41584-022-00800-9

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   32.286


× No keyword cloud information.
  1 in total

1.  Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial.

Authors:  Felice Rivellese; Anna E A Surace; Katriona Goldmann; Elisabetta Sciacca; Cankut Çubuk; Giovanni Giorli; Christopher R John; Alessandra Nerviani; Liliane Fossati-Jimack; Georgina Thorborn; Manzoor Ahmed; Edoardo Prediletto; Sarah E Church; Briana M Hudson; Sarah E Warren; Paul M McKeigue; Frances Humby; Michele Bombardieri; Michael R Barnes; Myles J Lewis; Costantino Pitzalis
Journal:  Nat Med       Date:  2022-05-19       Impact factor: 87.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.